Related Experiment Video
Updated: Jul 22, 2026
Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding
Published on: August 22, 2016
Decorin and suramin inhibit ocular fibroblast collagen production
H Mietz1, P Chévez-Barrios, M W Lieberman
1Department of Pathology, Baylor College of Medicine, Houston, Texas, USA. h.mietz@uni-koeln.de
Background:
The process of ocular wound healing with respect to glaucomatous filtering procedures is of current interest. Delaying this response in patients could possibly lead to more favorable surgical results. So far, only highly toxic antimetabolites have come into frequent clinical use. The possible efficacy of other groups of substances such as growth factor inhibitors has not yet been examined in vitro.
Methods:
We exposed Tenon's capsule fibroblasts in tissue culture to various concentrations of decorin and suramin. The dose responses of type I and type III collagen to these inhibitors were measured using an ELISA-type dot blot assay. Total cellular protein production was assayed by measuring the incorporation of tritiated leucine.
Results:
At a concentration of 10 micrograms/ml, suramin reduced the collagen production by more than 80%. Decorin, at a concentration of 100 micrograms/ml, reduced type I collagen production by about 50% while type III collagen was reduced by 80%. At these concentrations, the total cellular protein production was not inhibited.
Conclusions:
Both suramin and decorin, which specifically inhibit the action of growth factors on target cells, reduce the production of collagen synthesis by Tenon's capsule fibroblasts. This is a specific effect, because total protein production is not influenced. This sets these substances apart from antimetabolites. Decorin and suramin may have clinical relevance in that they appear to interfere with ocular wound healing more specifically than the substances so far frequently used.
Insights
Decorin and suramin effectively inhibit collagen production by Tenon's capsule fibroblasts, offering a specific approach to modulating ocular wound healing. These growth factor inhibitors show promise compared to current treatments.
Area of Science:
- Ophthalmology
- Wound Healing Research
- Cell Biology
Background:
- Ocular wound healing is critical for glaucomatous filtering procedures.
- Current treatments often use toxic antimetabolites.
- Growth factor inhibitors' efficacy in ocular wound healing is unexplored.
Purpose of the Study:
- To investigate the in vitro effects of decorin and suramin on Tenon's capsule fibroblasts.
- To assess their impact on collagen production and total protein synthesis.
Main Methods:
- Tenon's capsule fibroblasts were cultured and exposed to varying concentrations of decorin and suramin.
- Collagen types I and III production was quantified using ELISA-type dot blot.
- Total cellular protein synthesis was measured via tritiated leucine incorporation.
Main Results:
- Suramin (10 µg/ml) reduced collagen production by over 80%.
- Decorin (100 µg/ml) decreased type I collagen by ~50% and type III by 80%.
- Neither substance inhibited total protein production at tested concentrations.
Conclusions:
- Decorin and suramin specifically inhibit collagen synthesis by Tenon's capsule fibroblasts.
- This targeted effect on collagen production differs from non-specific antimetabolites.
- Decorin and suramin represent potential therapeutic agents for modulating ocular wound healing.
Related Concept Videos
01:13Collagens are the Major Structural Proteins of ECM
Connective tissue proper includes loose...
01:11Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
01:05Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can exist in...
01:16Clot Retraction and Fibrinolysis